Literature DB >> 34057098

Validating a Seated Virtual Reality Threat Paradigm for Inducing Anxiety and Freezing of Gait in Parkinson's Disease.

Dione Y L Quek1, Kristin Economou1, Hamish MacDougall2, Simon J G Lewis1, Kaylena A Ehgoetz Martens1,3.   

Abstract

BACKGROUND: Although prior research has established that freezing of gait (FOG) in Parkinson's disease (PD) is associated with anxiety, only one study to date has directly manipulated anxiety levels to induce FOG.
OBJECTIVE: The current study aimed to replicate these previous findings and evaluate whether a seated version of a 'threat' virtual reality (VR) paradigm could induce anxiety and provoke FOG.
METHODS: Twenty-four PD patients with FOG were assessed across various threat conditions in both a walking VR paradigm (Experiment 1) and a seated VR paradigm (Experiment 2). Both paradigms manipulated the height (i.e., elevated vs ground) and width (wide vs narrow) of the planks participants were instructed to walk across.
RESULTS: Across both experiments, the Elevated + Narrow condition provoked significantly greater number of freezing episodes compared to all other conditions. Higher levels of self-reported anxiety were reported during the Elevated+Narrow condition compared to all other conditions in Experiment 1, and compared to the Ground condition in Experiment 2.
CONCLUSION: These findings confirm that anxiety contributes to FOG and validates the use of a seated VR threat paradigm for provoking anxiety-related freezing. This enables future studies to combine this paradigm with functional MRI to explore the neural correlates underlying the role of anxiety in FOG.

Entities:  

Keywords:  Parkinson’s disease; Virtual reality; anxiety; freezing of gait; threat

Mesh:

Year:  2021        PMID: 34057098     DOI: 10.3233/JPD-212619

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  1 in total

1.  The Contribution of Noradrenergic Activity to Anxiety-Induced Freezing of Gait.

Authors:  Natasha L Taylor; Gabriel Wainstein; Dione Quek; Simon J G Lewis; James M Shine; Kaylena A Ehgoetz Martens
Journal:  Mov Disord       Date:  2022-04-05       Impact factor: 9.698

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.